AQUESTIVE THERAPEUTICS INC's ticker is AQST and the CUSIP is 03843E104. A total of 58 filers reported holding AQUESTIVE THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 0.33 and the average weighting 1.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $1,290,120 | +21911.9% | 496,200 | -63.9% | 0.00% | -77.8% |
Q1 2024 | $5,861 | +128.2% | 1,375,800 | +8.2% | 0.01% | +125.0% |
Q4 2023 | $2,568 | +48.6% | 1,271,500 | +12.6% | 0.00% | +33.3% |
Q3 2023 | $1,728 | -14.9% | 1,129,189 | -8.2% | 0.00% | 0.0% |
Q2 2023 | $2,030 | +243.5% | 1,230,196 | +137.1% | 0.00% | +200.0% |
Q1 2023 | $591 | +41.7% | 518,800 | +12.1% | 0.00% | 0.0% |
Q4 2022 | $417 | -100.0% | 462,737 | -48.6% | 0.00% | 0.0% |
Q3 2022 | $1,054,000 | +34.3% | 900,800 | -26.5% | 0.00% | 0.0% |
Q2 2022 | $785,000 | +772.2% | 1,226,400 | +3475.5% | 0.00% | – |
Q1 2022 | $90,000 | +104.5% | 34,300 | +204.7% | 0.00% | – |
Q4 2021 | $44,000 | -94.7% | 11,257 | -94.1% | 0.00% | -100.0% |
Q3 2021 | $827,000 | -15.1% | 189,669 | -22.7% | 0.00% | 0.0% |
Q2 2021 | $974,000 | -33.0% | 245,448 | -9.7% | 0.00% | -50.0% |
Q4 2020 | $1,454,000 | +125.8% | 271,800 | -7.6% | 0.00% | +100.0% |
Q1 2020 | $644,000 | +40.0% | 294,051 | +272.2% | 0.00% | – |
Q4 2019 | $460,000 | – | 79,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bratton Capital Management, L.P. | 9,810,958 | $42,776,000 | 100.00% |
Latash Investments, LLC | 243,134 | $1,060,000 | 0.66% |
Bracebridge Capital, LLC | 428,571 | $1,869,000 | 0.16% |
GSA CAPITAL PARTNERS LLP | 297,229 | $1,296,000 | 0.13% |
PDT Partners, LLC | 76,100 | $332,000 | 0.02% |
Jump Financial, LLC | 49,700 | $216,000 | 0.02% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 183,000 | $798,000 | 0.02% |
IndexIQ Advisors LLC | 86,461 | $377,000 | 0.01% |
Financial Advocates Investment Management | 17,000 | $74,000 | 0.01% |
Brandywine Global Investment Management, LLC | 125,016 | $545,000 | 0.00% |